AI USE CASE
Digital Pathology Slide Analysis
Automates cancer detection and tumor grading from histopathology slides for pathology labs.
What it is
Deep learning models analyze digitized histopathology slides to detect cancer, grade tumors, and identify biomarkers with diagnostic accuracy comparable to expert pathologists. It also enables pathologists to prioritize high-risk cases, shortening turnaround times from days to hours in high-volume settings.
Data you need
Large repository of digitized whole-slide images (WSIs) with associated pathologist annotations and confirmed diagnoses for model training and validation.
Required systems
- data warehouse
Why it works
- Engage pathologists early in dataset curation and annotation to ensure clinical relevance and build trust.
- Choose a vendor with existing regulatory clearance (CE/IVD or equivalent) to avoid approval bottlenecks.
- Integrate the AI viewer directly into the existing pathology workstation or LIS to minimize workflow disruption.
- Establish a continuous validation pipeline to monitor model performance across scanner types and tissue preparations.
How this goes wrong
- Insufficient annotated training data leads to poor model generalization across different staining protocols or scanner vendors.
- Regulatory approval (CE marking, FDA clearance) delays or blocks clinical deployment by months or years.
- Pathologist resistance or lack of trust in AI outputs results in low adoption and workflow bypass.
- Model performance degrades silently over time due to scanner upgrades or lab protocol changes without continuous monitoring.
When NOT to do this
Do not attempt to build a custom model from scratch if your lab has fewer than 5,000 annotated slides and no in-house ML team, the cost and time to regulatory clearance will far outweigh the benefit.
Example vendors
This page describes an idea. It gives no budget or timeline: those depend on your company. The free diagnostic tells you which ideas fit your situation.